EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glycosaminoglycan Recognition by YKL-40: Potential Regulation in Disease

Unnur Magnusdottir, Kristinn R. Oskarsson, Jens G. Hjorleifsson, Jon M. Einarsson, Finnbogi R. Thormodsson

Biomolecules · 13.11.2026 · 16 (11) · 1659

DOI: 10.3390/biom16111659 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 13.11.2026. Verfasst von Unnur Magnusdottir und 4 weiteren Autor:innen. Die Arbeit nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Genis hf.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

YKL-40 (CHI3L1) is a secreted chitinase-like protein involved in inflammation, tissue remodeling, angiogenesis, and cancer. Although its biological activities have been extensively investigated, the molecular mechanisms regulating its extracellular interactions remain incompletely understood. YKL-40 binds several glycosaminoglycans (GAGs), including heparin (hep), heparan sulfate (HS), dermatan sulfate (DS), and hyaluronan (HA). YKL-40-GAG interactions are influenced by the GAG chain length, sulfation, and uronic acid composition, suggesting that YKL-40 selectively recognizes specific structural features of GAG chains rather than electrostatic interactions alone. YKL-40 is known to interact with the HS-containing cell-surface receptors CD44v3, syndecan-1, and syndecan-4, which have been implicated in YKL-40-mediated signaling associated with tumor progression and angiogenesis. Because HS structures are dynamically regulated through sulfation and the C5-epimerization of D-glucuronic acid (GlcA) to L-iduronic acid (IdoA), pathological remodeling may alter the binding properties of HS chains of these receptors. This hypothesis-driven review examines the structural determinants of YKL-40-GAG recognition and proposes a mechanism by which disease-associated changes in HS sulfation, the uronic acid composition, and motif organization could alter YKL-40 binding affinity for HS-containing receptors, potentially influencing their downstream signaling. However, whether such remodeling directly alters YKL-40 binding or signaling remains to be experimentally established. Understanding how receptor-associated HS structures influence YKL-40 recognition may provide new insights into its context-dependent biological activity and potential therapeutic targeting.

Förderung

  • Genis hf

Zitieren

APA

Magnusdottir, U., Oskarsson, K. R., Hjorleifsson, J. G., Einarsson, J. M., & Thormodsson, F. R. (2026). Glycosaminoglycan Recognition by YKL-40: Potential Regulation in Disease. Biomolecules, 16(11), 1659. https://doi.org/10.3390/biom16111659

Vancouver

Magnusdottir U, Oskarsson KR, Hjorleifsson JG, Einarsson JM, Thormodsson FR. Glycosaminoglycan Recognition by YKL-40: Potential Regulation in Disease. Biomolecules. 2026;16(11):1659. doi:10.3390/biom16111659

BibTeX
@article{Magnusdottir2026,
  author = {Magnusdottir, Unnur and Oskarsson, Kristinn R. and Hjorleifsson, Jens G. and Einarsson, Jon M. and Thormodsson, Finnbogi R.},
  title = {Glycosaminoglycan Recognition by YKL-40: Potential Regulation in Disease},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {1659},
  doi = {10.3390/biom16111659}
}
Kostenlos starten →